Business

ONJCRI Evaluates Monepantel Anti-Cancer Mechanism

ONJCRI Evaluates Monepantel Anti-Cancer Mechanism

articleNeurizon Therapeutics LimitedSeptember 29, 20204/company/neurizon-therapeutics-limited/news/onjcri-evaluates-monepantel-anti-cancer-mechanism
ONJCRI Evaluates Monepantel Anti-Cancer Mechanism

About this update from Neurizon Therapeutics Limited

[{"type":"text","content":"Neurizon Therapeutics Limited has released a press release. View Attachment","length":248,"tagName":"div"}]

More updates from Neurizon Therapeutics Limited